Clinical Question: Does intensive t...

Clinical Question: Does intensive treatment of token 1 diabetes reduce the risk of cardiovascular events?

Setting: Outpatient (specialty)

inquiry Design: randomized controlled trial (double-blinded)

Allocation: Uncertain

Synopsis: This subject of attention was a long-term follow-up of patients in the landmark Diabetes have charge of and Complications Trial (DCCT). Of 1441 patients originally randomized to intensive or conventional treatment of symbol 1 diabetes between 1983 and 1989 1421 complet the research in 1993, and 1,182 were still available for follow-up in 2004 At the [i]finale[/i] of the initial 6.5-year investigation patients in the intensive superintend group had a mean A1C of 74 percent compared with 91 percent in the usual treatment group

Almost all patients opt for intensive treatment in a less degree than the supervision of their local physician in 1993 and at 2004, the mean A1C was similar between disposes (7.9 versus 7.8 percent). clusters were similar in 2004 regarding vital current pressure; lipid control; and use of medications like as hormone therapy, aspirin, statins, angiotensin-converting enzyme inhibitors, and beta blocker according to 2004, the likelihood that a patient would experience a cardiovascular affair (i.e., cardiovascular death, nonfatal or silent acute myocardial infarction, revascularization, confirmed angina, or nonfatal stroke) was lower in the intensive treatment assign places to (0.38 versus 0.80 per 100 patient-years of follow-up; P = 008) enjoin another way, this means intensive therapy stoped one event for every 25 patients treated throughout 10 years. There was no difference in the likelihood of renal failure (1 percent in each group) and data regarding all-cause mortality were not reported. Given the relatively young average age of this arrange (45 years), it is not surprising that there was no difference reported regarding the latter outcomes

Bottom Line: This extension of DCCT provides the first high-quality evidence that intensive treatment of archetype 1 diabetes reduces the risk of adverse cardiovascular issues Although the relative risk reduction was greater than 50 percent the absolute risk reduction was becoming Note that this effect has not been shown in patients with sign 2 diabetes, although many patients and physicians believe otherwise, and data regarding all-cause mortality or adverse drifts of intensive treatment (e.g., hypoglycemic episodes or traffic incidents) are not reported. (Level of Evidence: 1b)

MARK EBELL, MD MS

contemplation Reference: Nathan DM, et al, for the Diabetes mastery and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) inquiry Research Group. Intensive diabetes treatment and cardiovascular disease in patients with token 1 diabetes. N Engl J M December 22 2005;353:2643-53

Used with permission from Ebell M Intensive tx of original 1 DM reduces CV circumstances Accessed online January 18, 2006 at: http://www.InfoPOEMs.com.

COPYRIGHT 2006 American Academy of Family Physicians

COPYRIGHT 2006 Gale Group